Valuation: AVRA Medical Robotics, Inc.

Market Cap 75Cr 66Cr 61Cr 56Cr 105.87Cr 7.22TCr 107.25Cr 727.8Cr 284.69Cr 3.54TCr 281.72Cr 275.65Cr 12TCr P/E 2026 *
-62.5x
P/E 2027 * -62.5x
Enterprise Value 75Cr 66Cr 61Cr 56Cr 105.87Cr 7.22TCr 107.25Cr 727.8Cr 284.69Cr 3.54TCr 281.72Cr 275.65Cr 12TCr EV / Sales 2026 *
12.6x
EV / Sales 2027 * 9.98x
Free-Float
-
Yield 2026 *
-
Yield 2027 * -
Change 5-day change 1-year change 3-year change Capi.($)
-3.50%-.--% - - 5.12Cr
-0.18%-4.18%-1.02%+2.10% 4.87TCr
+1.61%-0.36%+378.56%+583.41% 3.84TCr
+2.61%+4.84%+8.19%+65.22% 3.45TCr
-1.12%-2.86%+25.52%-10.93% 3.4TCr
-0.58%-2.00%-0.07%+31.08% 2.68TCr
+1.37%-3.78% - - 1.56TCr
+0.71%+0.28%+70.48%+115.34% 1.51TCr
-2.03%+0.23%+13.53%+15.87% 1.42TCr
+0.26%+0.31%+16.08%-32.65% 1.27TCr
Average -0.09%-1.04%+63.91%+96.18% 2.67TCr
Weighted average by Cap. +0.40%-1.36%+76.11%+119.16%

Financials

2026 *2027 *
Net sales 5.94Cr 5.21Cr 4.83Cr 4.44Cr 8.38Cr 571.58Cr 8.49Cr 58Cr 23Cr 280.23Cr 22Cr 22Cr 969.13Cr 7.52Cr 6.6Cr 6.11Cr 5.62Cr 11Cr 723.61Cr 11Cr 73Cr 29Cr 354.77Cr 28Cr 28Cr 1.23TCr
Net income -1.2Cr -1.05Cr -97.52L -89.71L -1.69Cr -115.47Cr -1.71Cr -12Cr -4.55Cr -57Cr -4.5Cr -4.41Cr -195.78Cr -1.4Cr -1.23Cr -1.14Cr -1.05Cr -1.97Cr -134.71Cr -2Cr -14Cr -5.31Cr -66Cr -5.26Cr -5.14Cr -228.41Cr
Net Debt - -
Logo AVRA Medical Robotics, Inc.
SS Innovations International, Inc., formerly AVRA Medical Robotics, Inc, is a medical robotics company. The Company is engaged in developing a fully autonomous medical robotic system using its software, which integrates artificial intelligence (AI) and deep learning, or machine learning (DL). By using an AI and DL-enhanced software program, it is creating an intelligent robotic system that robotizes a range of medical procedures. It is developing a treatment-independent autonomous robotics system utilizing its AI-driven precision guidance system, applicable to a variety of minimally and non-invasive procedures, with a focus on skin resurfacing aesthetic procedures. Its medical robotic system is being developed to deliver skin resurfacing treatments, such as micro-needling and laser therapies. Its autonomous medical robotics system is being developed to be compatible with available surgical tools and end-effectors, enabling it to enter the micro-needling and laser solutions market.
Employees
-